Literature DB >> 6112449

Rubella viraemia and antibody responses after rubella vaccination and reimmunization.

H H Balfour, K E Groth, C K Edelman, D P Amren, J M Best, J E Banatvala.   

Abstract

Eleven 4-13 year old schoolgirls, who were seronegative by haemagglutination inhibition (HI) and radioimmunoassay (RIA) tests despite having been given HPV77-DE5 vaccine 3-9 years previously, were revaccinated with RA27/3. They showed evidence of residual immunity since they had accelerated immune responses, little or no rubella-specific IgM, no viraemia, and no vaccine-induced reactions. In contrast, all but one of the five adult women who were primary vaccinees showed a more delayed immune response. Three of four women tested had viraemia and two had vaccine-induced reactions. Enhanced HI and enhanced RIA showed that many of the schoolgirls had antibody before challenge, as did a fifth adult, who also showed an accelerated immune response, yet became viraemic.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112449     DOI: 10.1016/s0140-6736(81)92243-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Rubella in the United States: toward a strategy for disease control and elimination.

Authors:  K L Herrmann
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Comparison of five different methods of rubella IgM antibody testing.

Authors:  H Cubie; E Edmond
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

Review 3.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.

Authors:  S E Robertson; F T Cutts; R Samuel; J L Diaz-Ortega
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  Clinically apparent rubella reinfection with a detectable rubella specific IgM response.

Authors:  P Morgan-Capner; C Burgess; R M Ireland; J C Sharp
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

5.  Rubella vaccination: remaining problems.

Authors:  J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

6.  Rubella vaccination: a course becomes clear.

Authors:  J S Spika; D K Clogg
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

7.  Persistence of rubella antibody 8-18 years after vaccination.

Authors:  S O'Shea; J M Best; J E Banatvala; W C Marshall; J A Dudgeon
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

8.  Rubella antibodies detected by several commercial immunoassays in hemagglutination inhibition-negative sera.

Authors:  K T Kleeman; D J Kiefer; S P Halbert
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

9.  Adult onset Still's disease and viral infections.

Authors:  J M Wouters; J van der Veen; L B van de Putte; D J de Rooij
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

10.  Rubella embryopathy after previous maternal rubella vaccination.

Authors:  G Enders; A Calm; J Schaub
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.